Drug-drug interaction mediated by inhibition and induction of P-glycoprotein

被引:232
作者
Lin, JH [1 ]
机构
[1] Merck Res Labs, Dept Drug Metab, West Point, PA 19486 USA
关键词
P-glycoprotein-mediated drug interactions; genetic polymorphism; saturable efflux transport; blood-brain barrier;
D O I
10.1016/S0169-409X(02)00171-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P-glycoprotein (P-gp), the most extensively studied ATP-binding cassette transporter, functions as a biological barrier by extruding toxic substances and xenobiotics out of cells. In vitro and in vivo studies have demonstrated that P-gp plays a significant role in drug absorption and disposition. Like cytochrome P450 enzymes, inhibition and induction Of P7-gp have been reported as the causes of drug-drug interactions. Because many prototypic inhibitors and inducers affect both CYP3A4 and P-gp, many drug interactions caused by these inhibitors and inducers involve these two systems. Clinically, it is very difficult to quantitatively differentiate P-gp-mediated drug interactions versus CYP3A4-mediated drug interactions, unless their relative contributions can be accurately estimated. Therefore, care should be exercised when interpreting drug interaction data and exploring the underlying mechanisms of drug interactions. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:53 / 81
页数:29
相关论文
共 157 条
  • [1] Advani R, 2001, CLIN CANCER RES, V7, P1221
  • [2] EVIDENCE FOR A POLARIZED EFFLUX SYSTEM IN CACO-2 CELLS CAPABLE OF MODULATING CYCLOSPORINE-A TRANSPORT
    AUGUSTIJNS, PF
    BRADSHAW, TP
    GAN, LSL
    HENDREN, RW
    THAKKER, DR
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) : 360 - 365
  • [3] Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein
    Ayesh, S
    Shao, YM
    Stein, WD
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1996, 1316 (01): : 8 - 18
  • [4] BALLET F, 1987, CANCER CHEMOTH PHARM, V19, P240
  • [5] ISOLATION AND CULTURE OF HUMAN BRAIN MICROVESSEL ENDOTHELIAL-CELLS FOR THE STUDY OF BLOOD-BRAIN-BARRIER PROPERTIES IN-VITRO
    BIEGEL, D
    SPENCER, DD
    PACHTER, JS
    [J]. BRAIN RESEARCH, 1995, 692 (1-2) : 183 - 189
  • [6] SXR, a novel steroid and xenobiotic-sensing nuclear receptor
    Blumberg, B
    Sabbagh, W
    Juguilon, H
    Bolado, J
    van Meter, CM
    Ono, ES
    Evans, RM
    [J]. GENES & DEVELOPMENT, 1998, 12 (20) : 3195 - 3205
  • [7] DIFFERENTIAL INHIBITION BY CYCLOSPORINS OF PRIMARY-ACTIVE ATP-DEPENDENT TRANSPORTERS IN THE HEPATOCYTE CANALICULAR MEMBRANE
    BOHME, M
    BUCHLER, M
    MULLER, M
    KEPPLER, D
    [J]. FEBS LETTERS, 1993, 333 (1-2) : 193 - 196
  • [8] Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer
    Boote, DJ
    Dennis, IF
    Twentyman, PR
    Osborne, RJ
    Laburte, C
    Hensel, S
    Smyth, JF
    Brampton, MH
    Bleehen, NM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 610 - 618
  • [9] Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury - Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial
    Bracken, MB
    Shepard, MJ
    Holford, TR
    LeoSummers, L
    Aldrich, EF
    Fazl, M
    Fehlings, M
    Herr, DL
    Hitchon, PW
    Marshall, LF
    Nockels, RP
    Pascale, V
    Perot, PL
    Piepmeier, J
    Sonntag, VKH
    Wagner, F
    Wilberger, JE
    Winn, HR
    Young, W
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (20): : 1597 - 1604
  • [10] Tissue distribution and chemical induction of multiple drug resistance genes in rats
    Brady, JM
    Cherrington, NJ
    Hartley, DP
    Buist, SC
    Li, N
    Klaassen, CD
    [J]. DRUG METABOLISM AND DISPOSITION, 2002, 30 (07) : 838 - 844